Literature DB >> 12386917

Association between prostate cancer and serum testosterone levels.

Ping L Zhang1, Seymour Rosen, Ravindra Veeramachaneni, Jerry Kao, William C DeWolf, Glenn Bubley.   

Abstract

BACKGROUND: The purpose of the current study was to determine whether the presence of prostate cancer altered serum testosterone levels.
METHODS: Initially, we evaluated both serum total and free testosterone levels in patients with either high-grade (n = 18) or moderate-grade (n = 146) prostate cancer, detected by prostate needle biopsies. Then both serum total and free testosterone levels, before and after prostatectomy, were compared in 79 of the 164 men with prostate cancer.
RESULTS: In the first setting, serum total and free testosterone levels (307 +/- 24 ng/dl and 1.14 +/- 0.09 ng/dl) in patients with high-grade prostate cancer were significantly lower than those in patients with moderate-grade prostate cancer (452 +/- 12 ng/dl and 1.51 +/- 0.04 ng/dl) and those without prostate cancer (451 +/- 17 ng/dl and 1.55 +/- 0.06 ng/dl). After prostatectomy in 79 patients with prostate cancer, serum levels of both total and free testosterone (511 +/- 15 ng/dl and 1.78 +/- 0.05 ng/dl) were found significantly elevated when compared with their respective presurgical total and free testosterone levels (450 +/- 17 ng/dl and 1.60 +/- 0.06 ng/dl).
CONCLUSION: Our findings show that serum total and free testosterone levels in patients with prostate cancer are altered, supporting the possibility that prostate cancer may inhibit serum testosterone levels. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12386917     DOI: 10.1002/pros.10140

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  19 in total

1.  Lower Circulating Androgens Are Associated with Overall Cancer Risk and Prostate Cancer Risk in Men Aged 25-84 Years from the Busselton Health Study.

Authors:  Yi X Chan; Matthew W Knuiman; Mark L Divitini; David J Handelsman; John P Beilby; Bu B Yeap
Journal:  Horm Cancer       Date:  2018-08-10       Impact factor: 3.869

Review 2.  Metabesity and urological cancers.

Authors:  Ali Atan
Journal:  Turk J Urol       Date:  2017-12-01

3.  Chronic exercise training attenuates prostate cancer-induced molecular remodelling in the testis.

Authors:  Bárbara Matos; Daniela Patrício; Magda C Henriques; Maria J Freitas; Rui Vitorino; Iola F Duarte; John Howl; Paula A Oliveira; Fernanda Seixas; José A Duarte; Rita Ferreira; Margarida Fardilha
Journal:  Cell Oncol (Dordr)       Date:  2020-10-19       Impact factor: 6.730

4.  Preoperative Plasma Levels of Total Testosterone Associated with High Grade Pathology-Detected Prostate Cancer: Preliminary Results of a Prospective Study in a Contemporary Cohort of Patients.

Authors:  Antonio B Porcaro; Nicolò De Luyk; Paolo Corsi; Marco Sebben; Alessandro Tafuri; Giovanni Cacciamani; Davide De Marchi; Irene Tamanini; Davide Inverardi; Matteo Brunelli; Maria A Cerruto; Gian L Salvagno; Gian C Guidi; Walter Artibani
Journal:  Curr Urol       Date:  2017-05-30

Review 5.  Meta-analysis of metabolic syndrome and prostate cancer.

Authors:  M Gacci; G I Russo; C De Nunzio; A Sebastianelli; M Salvi; L Vignozzi; A Tubaro; G Morgia; S Serni
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-02-21       Impact factor: 5.554

6.  Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer.

Authors:  Thomas Schnoeller; Florian Jentzmik; Ludwig Rinnab; Marcus V Cronauer; Ilija Damjanoski; Friedemann Zengerling; Andreas Al Ghazal; Mark Schrader; Andres J Schrader
Journal:  World J Urol       Date:  2012-07-05       Impact factor: 4.226

Review 7.  [Testosterone and the prostate].

Authors:  H Sperling; R Rossi; G Lümmen; H Rübben
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

8.  Is a decreased serum testosterone level a risk factor for prostate cancer? A cohort study of korean men.

Authors:  Bo Sung Shin; Eu Chang Hwang; Chang Min Im; Sun-Ouck Kim; Seung Il Jung; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park; Soo Bang Ryu
Journal:  Korean J Urol       Date:  2010-12-21

9.  Changes in Prostate Cancer Aggressiveness over a 12-Year Period in Korea.

Authors:  Doejung Kim; Daeheon Choi; Ju Hyun Lim; Jong Hyun Yoon; In Gab Jeong; Dalsan You; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  Korean J Urol       Date:  2012-10-19

10.  Prediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer.

Authors:  Boris Gershman; Irene M Shui; Meir Stampfer; Elizabeth A Platz; Peter H Gann; Howard L Sesso; Natalie DuPre; Edward Giovannucci; Lorelei A Mucci
Journal:  Eur Urol       Date:  2013-01-11       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.